Skip to main content
. 2004 Jun;48(6):2097–2100. doi: 10.1128/AAC.48.6.2097-2100.2004

FIG. 3.

FIG. 3.

Activities of 9 and 90 μM PF-18 against different GBS serotypes III (A) and Ib (B) in the presence or absence of 10 mg of a modified porcine surfactant preparation (Curosurf) per ml. The overall patterns of antibacterial activity of PF-18 against the different GBS subtypes were similar (see Fig. 2 for the results for GBS serotype Ia).